These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38986249)

  • 1. Human effector CD8
    Mietz J; Kaulfuss M; Egli L; Opitz L; Münz C; Chijioke O
    EBioMedicine; 2024 Aug; 106():105240. PubMed ID: 38986249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR5 and TIM-3 expressions define distinct exhausted T cell subsets in experimental cutaneous infection with
    Diupotex M; Zamora-Chimal J; Gajón JA; Bonifaz LC; Becker I
    Front Immunol; 2023; 14():1231836. PubMed ID: 37691941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition.
    Wildner NH; Walker A; Brauneck F; Ditt V; Peine S; Huber S; Haag F; Beisel C; Timm J; Schulze Zur Wiesch J
    Front Immunol; 2022; 13():886646. PubMed ID: 35734162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
    Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells.
    Martinez-Usatorre A; Carmona SJ; Godfroid C; Yacoub Maroun C; Labiano S; Romero P
    Front Immunol; 2020; 11():340. PubMed ID: 32174925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
    León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
    Front Immunol; 2020; 11():583382. PubMed ID: 33240271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
    Lee J; Lee K; Bae H; Lee K; Lee S; Ma J; Jo K; Kim I; Jee B; Kang M; Im SJ
    Front Immunol; 2023; 14():1117092. PubMed ID: 37409128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.
    Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39
    Lee YJ; Kim JY; Jeon SH; Nam H; Jung JH; Jeon M; Kim ES; Bae SJ; Ahn J; Yoo TK; Sun WY; Ahn SG; Jeong J; Park SH; Park WC; Kim SI; Shin EC
    Sci Immunol; 2022 Aug; 7(74):eabn8390. PubMed ID: 36026440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct CD137 costimulation of CD8 T cells promotes retention and innate-like function within nascent atherogenic foci.
    Xu MM; Ménoret A; Nicholas SE; Günther S; Sundberg EJ; Zhou B; Rodriguez A; Murphy PA; Vella AT
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1480-H1494. PubMed ID: 30978132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR-independent CD137 (4-1BB) signaling promotes CD8
    Pichler AC; Carrié N; Cuisinier M; Ghazali S; Voisin A; Axisa PP; Tosolini M; Mazzotti C; Golec DP; Maheo S; do Souto L; Ekren R; Blanquart E; Lemaitre L; Feliu V; Joubert MV; Cannons JL; Guillerey C; Avet-Loiseau H; Watts TH; Salomon BL; Joffre O; Grinberg-Bleyer Y; Schwartzberg PL; Lucca LE; Martinet L
    Immunity; 2023 Jul; 56(7):1631-1648.e10. PubMed ID: 37392737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive profile of TCF1
    Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z
    Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resident memory T cells, critical components in tumor immunology.
    Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E
    J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1/CTLA-4 Blockade Leads to Expansion of CD8
    Bufe S; Zimmermann A; Ravens S; Prinz I; Buitrago-Molina LE; Geffers R; Woller N; Kühnel F; Talbot SR; Noyan F; Manns MP; Wedemeyer H; Hardtke-Wolenski M; Jaeckel E; Davalos-Misslitz AC
    Liver Cancer; 2023 Jun; 12(2):129-144. PubMed ID: 37325488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD137
    Nong J; Wang J; Gao X; Zhang Q; Yang B; Yan Z; Wang X; Yi L; Wang Q; Gao Y; Hu A; Qin N; Wei P; Zhang H; Zhang S
    Scand J Immunol; 2019 Jun; 89(6):e12765. PubMed ID: 30921475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Mass Cytometry to Profile Human T Cell Exhaustion.
    Winkler F; Bengsch B
    Front Immunol; 2019; 10():3039. PubMed ID: 32038613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39 Is Expressed on Functional Effector and Tissue-resident Memory CD8+ T Cells.
    Isaacs JF; Degefu HN; Chen T; Kleist SA; Musial SC; Ford MA; Searles TG; Lin CC; Skorput AGJ; Shirai K; Turk MJ; Zanazzi GJ; Rosato PC
    J Immunol; 2024 Sep; 213(5):588-599. PubMed ID: 38975728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
    Ju F; Luo Y; Lin C; Jia X; Xu Z; Tian R; Lin Y; Zhao M; Chang Y; Huang X; Li S; Ren W; Qin Y; Yu M; Jia J; Han J; Luo W; Zhang J; Fu G; Ye X; Huang C; Xia N
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.